Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 31 | 2024 | 1931 | 5.660 |
Why?
|
Elasticity Imaging Techniques | 10 | 2021 | 388 | 2.570 |
Why?
|
Portal Vein | 2 | 2024 | 429 | 1.510 |
Why?
|
End Stage Liver Disease | 3 | 2021 | 353 | 1.300 |
Why?
|
Fatty Liver | 6 | 2024 | 778 | 1.110 |
Why?
|
Venous Thrombosis | 2 | 2024 | 1299 | 0.940 |
Why?
|
Lipoproteins, VLDL | 3 | 2018 | 201 | 0.760 |
Why?
|
Liver Diseases | 3 | 2021 | 1302 | 0.760 |
Why?
|
Liver Transplantation | 4 | 2021 | 2325 | 0.710 |
Why?
|
Ceruloplasmin | 3 | 2015 | 56 | 0.700 |
Why?
|
Hepatolenticular Degeneration | 3 | 2015 | 72 | 0.680 |
Why?
|
Adenosine Deaminase | 2 | 2021 | 251 | 0.670 |
Why?
|
Keratin-18 | 2 | 2016 | 38 | 0.650 |
Why?
|
Tissue and Organ Procurement | 2 | 2019 | 944 | 0.560 |
Why?
|
Serum | 1 | 2017 | 211 | 0.540 |
Why?
|
Liver Function Tests | 3 | 2016 | 524 | 0.540 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2024 | 2299 | 0.530 |
Why?
|
Rifamycins | 1 | 2015 | 26 | 0.520 |
Why?
|
Lactulose | 1 | 2015 | 31 | 0.520 |
Why?
|
Primary Health Care | 3 | 2021 | 4647 | 0.520 |
Why?
|
Lipase | 1 | 2018 | 324 | 0.520 |
Why?
|
Hepatitis C, Chronic | 4 | 2012 | 1031 | 0.510 |
Why?
|
Clinical Laboratory Techniques | 2 | 2019 | 749 | 0.510 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 707 | 0.490 |
Why?
|
Data Mining | 1 | 2020 | 553 | 0.490 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1652 | 0.470 |
Why?
|
Hepatic Encephalopathy | 1 | 2015 | 144 | 0.470 |
Why?
|
Liver | 9 | 2021 | 7509 | 0.450 |
Why?
|
Nutrition Assessment | 1 | 2016 | 727 | 0.430 |
Why?
|
Liver Neoplasms | 4 | 2024 | 4319 | 0.420 |
Why?
|
Patient Readmission | 2 | 2015 | 3323 | 0.370 |
Why?
|
Gastrointestinal Agents | 1 | 2015 | 509 | 0.360 |
Why?
|
Malnutrition | 1 | 2016 | 640 | 0.340 |
Why?
|
Alanine Transaminase | 3 | 2012 | 606 | 0.340 |
Why?
|
Predictive Value of Tests | 9 | 2024 | 15289 | 0.330 |
Why?
|
Hepatitis B Vaccines | 1 | 2010 | 186 | 0.330 |
Why?
|
Fibrosis | 3 | 2021 | 2042 | 0.320 |
Why?
|
Organ Transplantation | 1 | 2019 | 1150 | 0.320 |
Why?
|
Guideline Adherence | 3 | 2015 | 2283 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3334 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12293 | 0.310 |
Why?
|
Preventive Medicine | 1 | 2010 | 250 | 0.310 |
Why?
|
Weight Loss | 2 | 2016 | 2686 | 0.290 |
Why?
|
Rural Health Services | 1 | 2011 | 381 | 0.290 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2001 | 0.290 |
Why?
|
Interleukins | 1 | 2012 | 785 | 0.290 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2008 | 96 | 0.280 |
Why?
|
ROC Curve | 6 | 2021 | 3568 | 0.280 |
Why?
|
Male | 37 | 2024 | 359744 | 0.270 |
Why?
|
Preventive Health Services | 1 | 2011 | 570 | 0.270 |
Why?
|
Middle Aged | 29 | 2024 | 220352 | 0.270 |
Why?
|
Female | 37 | 2024 | 391270 | 0.260 |
Why?
|
Humans | 54 | 2024 | 760621 | 0.250 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15840 | 0.250 |
Why?
|
Hepacivirus | 1 | 2012 | 1334 | 0.250 |
Why?
|
Biopsy | 6 | 2021 | 6771 | 0.240 |
Why?
|
Hepatitis B | 1 | 2010 | 701 | 0.240 |
Why?
|
Linear Models | 4 | 2021 | 5877 | 0.230 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 796 | 0.230 |
Why?
|
Macrophages | 2 | 2020 | 5745 | 0.220 |
Why?
|
Hepatitis B, Chronic | 1 | 2007 | 403 | 0.210 |
Why?
|
Viral Load | 1 | 2012 | 3322 | 0.210 |
Why?
|
Prednisone | 1 | 2008 | 1565 | 0.210 |
Why?
|
Hip Fractures | 1 | 2011 | 989 | 0.210 |
Why?
|
Electronic Health Records | 1 | 2020 | 4775 | 0.210 |
Why?
|
Health Services Research | 1 | 2010 | 1810 | 0.210 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.200 |
Why?
|
Osteoporosis | 1 | 2011 | 1600 | 0.190 |
Why?
|
Logistic Models | 6 | 2024 | 13314 | 0.190 |
Why?
|
Kupffer Cells | 1 | 2021 | 143 | 0.190 |
Why?
|
Risk Assessment | 7 | 2020 | 24123 | 0.190 |
Why?
|
Aged | 18 | 2024 | 169152 | 0.190 |
Why?
|
Membrane Proteins | 1 | 2018 | 7850 | 0.190 |
Why?
|
Hospital Mortality | 1 | 2015 | 5425 | 0.190 |
Why?
|
Autocrine Communication | 1 | 2021 | 169 | 0.180 |
Why?
|
Retrospective Studies | 11 | 2024 | 80372 | 0.180 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11891 | 0.180 |
Why?
|
Polyethylene Glycols | 2 | 2019 | 1189 | 0.180 |
Why?
|
Quality Improvement | 1 | 2015 | 3836 | 0.170 |
Why?
|
Prospective Studies | 12 | 2024 | 54303 | 0.170 |
Why?
|
Paracrine Communication | 1 | 2021 | 277 | 0.170 |
Why?
|
Hepatitis, Alcoholic | 1 | 2021 | 109 | 0.170 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1824 | 0.170 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2176 | 0.170 |
Why?
|
Presumed Consent | 1 | 2019 | 2 | 0.170 |
Why?
|
Algorithms | 1 | 2020 | 13981 | 0.170 |
Why?
|
Hepatic Stellate Cells | 1 | 2020 | 119 | 0.160 |
Why?
|
Risk Factors | 9 | 2024 | 74359 | 0.160 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20080 | 0.160 |
Why?
|
Diet | 1 | 2016 | 8010 | 0.150 |
Why?
|
Dietary Supplements | 1 | 2011 | 3392 | 0.150 |
Why?
|
Body Mass Index | 1 | 2016 | 12914 | 0.150 |
Why?
|
Confidence Intervals | 2 | 2015 | 2932 | 0.150 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12159 | 0.150 |
Why?
|
Health Policy | 1 | 2010 | 2677 | 0.150 |
Why?
|
Heart Failure | 1 | 2022 | 11847 | 0.140 |
Why?
|
Angina, Unstable | 1 | 2022 | 926 | 0.140 |
Why?
|
Israel | 1 | 2019 | 722 | 0.140 |
Why?
|
Germany | 1 | 2018 | 873 | 0.130 |
Why?
|
Odds Ratio | 3 | 2015 | 9716 | 0.130 |
Why?
|
Sodium | 1 | 2021 | 1594 | 0.130 |
Why?
|
Adult | 20 | 2024 | 219994 | 0.130 |
Why?
|
Propensity Score | 1 | 2024 | 1928 | 0.130 |
Why?
|
Decision Support Systems, Clinical | 2 | 2015 | 1164 | 0.130 |
Why?
|
Area Under Curve | 2 | 2021 | 1636 | 0.130 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12531 | 0.130 |
Why?
|
Incidence | 2 | 2024 | 21392 | 0.130 |
Why?
|
Survival Analysis | 3 | 2019 | 10182 | 0.130 |
Why?
|
Hospitalization | 1 | 2015 | 10790 | 0.120 |
Why?
|
Lipoproteins, LDL | 1 | 2018 | 641 | 0.120 |
Why?
|
Fructose | 1 | 2016 | 287 | 0.120 |
Why?
|
Quality of Life | 1 | 2016 | 13308 | 0.120 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.120 |
Why?
|
Waiting Lists | 1 | 2019 | 763 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 506 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 317 | 0.110 |
Why?
|
Chronic Disease | 3 | 2019 | 9287 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2024 | 3804 | 0.110 |
Why?
|
Lipoproteins, HDL | 1 | 2018 | 667 | 0.110 |
Why?
|
Fibroblast Growth Factors | 1 | 2019 | 869 | 0.110 |
Why?
|
Vibration | 1 | 2015 | 327 | 0.110 |
Why?
|
Biopsy, Needle | 2 | 2016 | 1630 | 0.110 |
Why?
|
Hepatocytes | 1 | 2020 | 1229 | 0.110 |
Why?
|
Cost-Benefit Analysis | 2 | 2016 | 5508 | 0.100 |
Why?
|
Ultrasonography | 2 | 2015 | 5961 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2575 | 0.100 |
Why?
|
Insulin Resistance | 2 | 2016 | 3959 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 413 | 0.100 |
Why?
|
Western Australia | 1 | 2011 | 41 | 0.100 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1919 | 0.090 |
Why?
|
Cold Ischemia | 1 | 2011 | 67 | 0.090 |
Why?
|
Genotype | 2 | 2018 | 12960 | 0.090 |
Why?
|
Hepatitis B Antigens | 1 | 2010 | 39 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3817 | 0.090 |
Why?
|
Clinical Enzyme Tests | 1 | 2010 | 115 | 0.090 |
Why?
|
Cell-Derived Microparticles | 1 | 2012 | 161 | 0.090 |
Why?
|
Ribavirin | 1 | 2012 | 396 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 643 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2016 | 65017 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2015 | 522 | 0.090 |
Why?
|
Frail Elderly | 1 | 2015 | 752 | 0.080 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 624 | 0.080 |
Why?
|
Boston | 4 | 2016 | 9280 | 0.080 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 416 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2012 | 3061 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1724 | 0.080 |
Why?
|
Interferons | 1 | 2012 | 705 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2421 | 0.080 |
Why?
|
Cohort Studies | 4 | 2021 | 41335 | 0.080 |
Why?
|
Inflammation | 3 | 2015 | 10756 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3465 | 0.080 |
Why?
|
Prognosis | 3 | 2021 | 29658 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25942 | 0.080 |
Why?
|
Interferon-alpha | 1 | 2012 | 918 | 0.070 |
Why?
|
Radiography | 1 | 2019 | 6965 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2018 | 3765 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17790 | 0.070 |
Why?
|
Hepatitis B e Antigens | 1 | 2007 | 133 | 0.070 |
Why?
|
Registries | 2 | 2016 | 8469 | 0.070 |
Why?
|
Hyaluronic Acid | 1 | 2010 | 482 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9631 | 0.070 |
Why?
|
Hepatitis B virus | 1 | 2010 | 522 | 0.070 |
Why?
|
Carrier State | 1 | 2010 | 525 | 0.070 |
Why?
|
Diphosphonates | 1 | 2011 | 638 | 0.070 |
Why?
|
Death | 1 | 2011 | 678 | 0.070 |
Why?
|
Ubiquitin | 1 | 2011 | 838 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15789 | 0.070 |
Why?
|
United States | 4 | 2016 | 72461 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2019 | 12427 | 0.060 |
Why?
|
Drug Utilization | 1 | 2011 | 1195 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14660 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7475 | 0.060 |
Why?
|
Life Style | 1 | 2016 | 3896 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2011 | 1313 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4351 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10551 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1575 | 0.060 |
Why?
|
Age Factors | 2 | 2013 | 18416 | 0.060 |
Why?
|
Citrates | 1 | 2023 | 135 | 0.050 |
Why?
|
Citric Acid | 1 | 2023 | 123 | 0.050 |
Why?
|
DNA, Viral | 1 | 2010 | 2194 | 0.050 |
Why?
|
Disease Progression | 2 | 2020 | 13502 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6538 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1784 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 2420 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11071 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2010 | 1399 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2773 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3476 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6597 | 0.050 |
Why?
|
Drug Prescriptions | 1 | 2011 | 1673 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5791 | 0.050 |
Why?
|
Tissue Donors | 1 | 2011 | 2313 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2011 | 2062 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6479 | 0.050 |
Why?
|
Thioacetamide | 1 | 2020 | 22 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2021 | 256 | 0.040 |
Why?
|
Databases, Factual | 1 | 2016 | 8035 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2021 | 388 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58995 | 0.040 |
Why?
|
Hepatitis C | 1 | 2010 | 1579 | 0.040 |
Why?
|
Medication Adherence | 1 | 2011 | 2165 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2024 | 22053 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 928 | 0.040 |
Why?
|
Calcium | 1 | 2011 | 5725 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2696 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3291 | 0.040 |
Why?
|
Glucose-6-Phosphatase | 1 | 2016 | 72 | 0.030 |
Why?
|
Lipoprotein(a) | 1 | 2021 | 499 | 0.030 |
Why?
|
Transcription Factors | 1 | 2016 | 12103 | 0.030 |
Why?
|
Lipoproteins | 1 | 2021 | 882 | 0.030 |
Why?
|
Factor VII | 1 | 2015 | 139 | 0.030 |
Why?
|
Lipogenesis | 1 | 2016 | 210 | 0.030 |
Why?
|
Phagocytosis | 1 | 2020 | 1535 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5423 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1725 | 0.030 |
Why?
|
Vegetables | 1 | 2020 | 1196 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23376 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1539 | 0.030 |
Why?
|
Time Factors | 2 | 2011 | 40165 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2924 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 828 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2016 | 580 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2012 | 12965 | 0.030 |
Why?
|
Dietary Fats | 1 | 2020 | 1992 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39261 | 0.020 |
Why?
|
alpha-Fetoproteins | 1 | 2011 | 222 | 0.020 |
Why?
|
Primary Graft Dysfunction | 1 | 2011 | 111 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 26181 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8803 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29749 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 208 | 0.020 |
Why?
|
Hypertension, Portal | 1 | 2010 | 226 | 0.020 |
Why?
|
Immunoassay | 1 | 2011 | 746 | 0.020 |
Why?
|
California | 1 | 2011 | 1416 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3600 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15687 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2011 | 1023 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 867 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9501 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17165 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3839 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3598 | 0.010 |
Why?
|
Animals | 3 | 2020 | 167963 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7806 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5870 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81208 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14372 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18137 | 0.010 |
Why?
|
Graft Survival | 1 | 2011 | 3794 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 58741 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 4353 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4550 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12808 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20509 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36290 | 0.000 |
Why?
|
Concepts
(256)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_